an.restrepo
Submits third-party assay reports on material purchased directly. Based in Chennai.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
5
n=5
Annotations
0
n=0
Median purity submitted
99.28%
n=5
Suppliers covered
5
n=5
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042989 | L-Glutathione (reduced) | MKM | MKM-2511-F3901 | Janoshik | 2026-Q2 | 98.79 | 9.03 | 96.6 | Laboratory-retained | 0 | PASS |
| AX-2026-041844 | Selank | GSP | GSP-2512-H3291 | Janoshik | 2026-Q1 | 99.77 | 8.93 | 98.2 | Buyer-sourced | 0 | PASS |
| AX-2026-041904 | Semaglutide | SinoPep | SNP-2509-A4337 | Nordanalyt | 2026-Q1 | 98.55 | 4.69 | 104.6 | Buyer-sourced | 0 | PASS |
| AX-2025-021220 | MK-677 (Ibutamoren mesylate) | PPG | PPG-2508-N7944 | PeptideMeter | 2025-Q3 | 99.92 | 4.65 | — | Buyer-sourced | 0 | FAIL |
| AX-2024-004593 | Enclomiphene citrate | TFC | TFC-2404-J9626 | Janoshik | 2024-Q3 | 99.28 | 3.49 | 90.0 | Buyer-sourced | 0 | FAIL |